logo

For the Inventor, By the Inventor

Carrollton, TX, United States of America

Gradalis, Inc.


USPTO Granted Patents = 23


Trademarks = 3

Forward Citations = 105

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Donald Rao (16 out of 21 patents)

silverMedal John J Nemunaitis (13 out of 17 patents)

bronzeMedal Neil Senzer (11 out of 11 patents)

4.  Phillip B Maples (10 out of 15 patents)

5.  Nancy Smyth Templeton (6 out of 7 patents)

6.  David M Shanahan (5 out of 10 patents)

7.  F Charles Brunicardi (1 out of 4 patents)

8.  Ernest Bognar (1 out of 1 patent)

9.  Zhaohui Wang (0 patent)


23 patents:

1. 11400170 - Methods for treating cancers (2022-08-02),
2. 10253331 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2019-04-09),
3. 9914977 - Individualized cancer therapy (2018-03-13),
4. 9790518 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2017-10-17),
5. 9695422 - Furin-knockdown bi-functional RNA (2017-07-04),
6. 9528991 - Individualized cancer therapy (2016-12-27),
7. 9382589 - Individualized cancer therapy (2016-07-05),
8. 9157084 - Furin-knockdown bi-functional RNA (2015-10-13),
9. 9132146 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2015-09-15),
10. 8969068 - Processes for the preparation of highly pure plasmid compositions by enzymatic digestion of colanic acid (2015-03-03),
11. 8916530 - Individualized cancer therapy (2014-12-23),
12. 8906874 - Bi-functional shRNA targeting Stathmin 1 and uses thereof (2014-12-09),
13. 8808983 - shRNA molecules and methods of use thereof (2014-08-19),
14. 8758998 - Construction of bifunctional short hairpin RNA (2014-06-24),
15. 8735119 - Polypeptides having colanic acid-degrading activity (2014-05-27),
GRADALIS, Inc. is a biotechnology company focused on developing and commercializing personalized cancer immunotherapy solutions. With a mission to transform cancer treatment, GRADALIS leverages its proprietary Vigil technology to create individualized vaccines tailored to each patient's unique tumor. By reprogramming the patient's immune system to target and destroy cancer cells, GRADALIS aims to improve patient outcomes and provide hope to those affected by cancer.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

...
23 Patents

#8 in Carrollton, TX

#844 in Texas

#13,930 in US

#26,801 in the World

...
Carrollton, TX, United States of America

Gradalis, Inc.

Forward Citations = 105

8 inventors:

goldMedal Donald Rao (16 out of 21 patents)

silverMedal John J Nemunaitis (13 out of 17 patents)

bronzeMedal Neil Senzer (11 out of 11 patents)

4.  Phillip B Maples (10 out of 15 patents)

5.  Nancy Smyth Templeton (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…